about
Oral premalignancy: the roles of early detection and chemoprevention[Contribution and challenges of Big Data in oncology].New insights into the role of EMT in tumor immune escape.Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients.Gene expression profiling predicts the development of oral cancer.Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitorsEffect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML PatientsDetection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA.Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.Tumor lysis associated with sudden onset of syndrome of inappropriate antidiuretic hormone secretion.Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.Recent advances in non-small cell lung cancer biology and clinical management.Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.Non-canonical NOTCH3 signalling limits tumour angiogenesis.A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.Chemotherapy for recurrent/metastatic head and neck cancers.The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers[Cardiovascular toxicity of some cancer agents (others than anthracyclines, fluoropyrimidines and trastuzumab)].Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.Bibliometric analysis of a century of research on oral erythroplakia and leukoplakia.Anti-Programmed Death 1 (PD-1) Antibodies and the Pancreas: A Diabetic Storm Ahead?The SCN9A channel and plasma membrane depolarization promote cellular senescence through Rb pathway.Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response.Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.Chemotherapy for localized head and neck squamous cell cancers.Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth.Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapyPrognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy[Dose density and dose intensity in the treatment of breast cancer]Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer Cells
P50
Q27693327-6315F1BF-B73E-456C-A8C0-26A0B100F853Q30395736-617E0DBE-D480-4922-B5F0-1218CBEEB240Q33869781-09922487-F935-4917-88A2-888664D101FBQ34129436-652C04D6-3590-476F-BC38-9284A62544E7Q34782013-3C795CC5-1BC0-4316-9F78-F7C1BDEF4955Q35212644-6269813F-5111-43CF-82A2-A6ECF845EBF0Q36224678-62B9E2B6-1BB1-4DCA-8713-F5D177633043Q36254052-6D634F0F-FE58-41E7-9A98-C5BDCD130DAFQ36614118-B20A0B03-F761-4D9B-A4CB-9636AB44A642Q36631786-60A708BA-9D14-4461-86D1-4F3BC95EDD74Q36648996-A8798747-A259-4170-90E0-D528754CC92DQ36740677-E9BEBF26-755A-4FB3-BFFD-ADBE1AF986D8Q36888316-326BF48E-8D11-490F-A63B-FE8ED9DFFD7DQ37536763-D873225E-9668-434C-B68A-E1DB4E56C219Q38006129-CAE9BCF0-2F52-49AB-9751-4FF999B116D7Q38151412-6262BA04-6C57-4D8D-9545-AFF4B94CBB5FQ38151634-DC50B338-ABAA-42B5-A1C2-83C3183EF5ACQ38599419-8E98699D-0D84-4095-A044-8DC1ECF3AD8BQ38673797-07211F4A-BBA7-4930-BF74-94BF91590764Q38708251-23B1799A-DD61-4588-863B-8DFA34848628Q38811007-49457894-99E0-4293-ADD8-C9EDA37A8231Q39640226-E9B6B40C-02B1-4173-8C7A-7E5DF890A18CQ40348100-E19AB3A7-68B8-421B-82C9-4633CB5A4E8DQ41667207-95F10749-9FEF-4A47-9123-DFEBB0F25417Q41830195-B0804DBB-7982-44D3-8746-1161BAF4AFC1Q46495517-2A353D65-13A3-4164-8BA2-E15373217698Q46688979-8E148FA4-619A-477C-A5F1-8AE06F77DEDAQ47148669-CB7C0A6F-6096-4DB7-BCD6-2743D4E666D3Q48516014-C4C2C44A-99B9-4223-AF77-98E8FD2C2C8AQ49790990-EC988C10-586A-49C6-B38D-F7F83FBBDB9CQ49988025-8DECD795-44E8-4389-9AC5-FF5BF973AFB4Q50091452-5AB8CA48-963E-45FB-85DE-9ADBAC468405Q51795706-E7EA4796-234C-4939-9952-024D6AA6B6F2Q52607160-B5AB5D03-701E-438A-9CED-7DA29E1904F9Q52917229-7036CD97-589E-42F5-A760-56D93296A9F7Q54110583-561B1722-5457-4E44-9D1E-3D4A98CE39A2Q56979020-A4C31DFA-ACB9-49A9-9332-867087AF5645Q57461597-DD954E47-A5AA-47C9-95CF-0258EEB645EAQ57579772-A2BD334D-6C07-49A4-8135-73886ED55E81Q59797790-9A634C5A-8C56-493F-A29D-FB437128D1AA
P50
description
researcher
@en
wetenschapper
@nl
name
Pierre Saintigny
@en
Pierre Saintigny
@nl
type
label
Pierre Saintigny
@en
Pierre Saintigny
@nl
prefLabel
Pierre Saintigny
@en
Pierre Saintigny
@nl
P106
P31
P496
0000-0002-8090-9323